WOXITIL-125 contains Cefuroxime 125 mg in a convenient paediatric oral suspension, positioned for the treatment of selected susceptible bacterial infections. Its child-friendly liquid form supports flexible dosing and ease of administration, making it a useful PCD Pharma Paediatric Antibiotic portfolio product.
Selected susceptible bacterial infections.
No.
Use according to the prescribed age/weight-based dose. Complete the course and assess allergy history. Seek medical advice for severe diarrhea or hypersensitivity.
Diarrhea, nausea, vomiting, abdominal discomfort, headache and rash may occur.
WOXITIL-125: Cefuroxime inhibits bacterial cell-wall synthesis by binding to bacterial penicillin-binding proteins, resulting in bacterial destruction.
